Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher’s Disease

E-ISSN： 1875-533x|23|9|929-952

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.9, 2016-03, pp. : 929-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pathologies of and Enzyme Replacement Therapies for Lysosomal Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 4, 2006-08 ,pp. : 401-413

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Lysosomal Storage Disorders: Progress with Enzyme Replacement Therapy

By Rohrbach Marianne Clarke Joe T.R.

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2697-2716

Adis International

Access to resources Recommend Favorite

Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease

By Moore David F.

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 201-208

Adis International

Access to resources Recommend Favorite

Enzyme Replacement Therapy in Patients with Fabry's Disease

By Tsuboi K

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 574-581

Field House Publishing

Access to resources Recommend Favorite

Fabry disease: recent advances in enzyme replacement therapy

By Germain Dominique P

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1467-1476

Informa Healthcare

Access to resources Recommend Favorite